SBIR/STTR Research Award

A novel antioxidant delivery system, Pro-NP™, for protection against UV-related skin cancer

Award identifier b59d67cdee290bd6971bffabe29c48f8a950e21686e254cb34f037bf78e46996Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$261,150

Program and phase

SBIR · Phase I

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PROTRANSIT NANOTHERAPY LLC
Proposal award date
2021-06-01
Contract end date
2022-05-31
UEI
F32QSKPPN192
Solicitation number
PA20-260
Topic code
NIAMS

Research abstract

ABSTRACT This project aims to develop a skincare product to prevent ultraviolet (UV)-induced skin cancer with a novel antioxidant delivery system, Pro-NP™, for topical application alone or as an additive to commercial sunblock. Skin cancer is more common than all other cancers combined and affects millions of Americans every year. UV exposure from the sun or tanning beds causes the production of reactive oxygen species (ROS), which overwhelms the skin’s natural antioxidant defense and leads to oxidative stress, photoaging, and skin cancer. While commercial sunscreens can reduce the risk of developing skin cancer, they are poor at blocking UV-A rays responsible for most of the cutaneous ROS production. The topical application of exogenous antioxidants could potentially combat UV generated ROS; however, in their native state, many antioxidants are too unstable to absorb to the deeper layers of the skin effectively. The natural defense system of the skin against UV-induced oxidative stress includes antioxidants superoxide dismutase (SOD) and catalase (CAT), essential enzymes that neutralize the detrimental effects of ROS. Unfortunately, the catalytic activity of native SOD and CAT are short- lived and rapidly cleared, a limiting factor on current therapeutic strategies based on exogenous delivery. ProTransit has developed a proprietary antioxidant delivery system, Pro-NP™, specially formulated for the slow- sustained release of SOD and CAT, to overcome the limitation of the antioxidant’s short half-life. The development of our dermatological product capitalizes on the recent advances of nanotechnology to overcome the biological barriers of using antioxidants to counteract skin damage caused by ROS. Our preliminary studies are promising and demonstrate that Pro-NP is non-toxic in humans and penetrates to the deepest layers of the skin to release active SOD and CAT, reduces DNA damage after UV exposure, and prevents the degradation of essential skin protein fibers like elastin and collagen. The overall objective of this study is to optimize the formulation of plant-based SOD and CAT in Pro-NP, determine the window of efficacy, compare the effectiveness of Pro-NP to commercially available sunscreens, and evaluate the potential of co-application of Pro-NP with commercial sunscreens. Our long-term goal is to develop novel, next-generation skincare products for topical application to prevent UV-induced skin damage and ultimately to reduce the incidence of skin cancer.NARRATIVE ProTransit is developing a novel, next generation skin care product, Pro-NP™, for the topical application of nanoformulated super antioxidants to prevent UV-induced skin cancer. Our nanoformulation can penetrate deep into the skin to counteract oxidative stress that leads to skin damage. Our overall objective is to optimize the formulation and evaluate the potential to use Pro-NP™ as an additive to commercial sunscreens.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2020–2021). Reported award amounts total $521,088. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.